| 000 | 02423 a2200697 4500 | ||
|---|---|---|---|
| 005 | 20250516051345.0 | ||
| 264 | 0 | _c20120118 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1873-7544 | ||
| 024 | 7 |
_a10.1016/j.neuroscience.2011.07.039 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, L | |
| 245 | 0 | 0 |
_aPhosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice. _h[electronic resource] |
| 260 |
_bNeuroscience _cOct 2011 |
||
| 300 |
_a399-410 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Newborn |
| 650 | 0 | 4 |
_aBrain-Derived Neurotrophic Factor _xpharmacology |
| 650 | 0 | 4 |
_aBromodeoxyuridine _xmetabolism |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCyclic Nucleotide Phosphodiesterases, Type 5 _xmetabolism |
| 650 | 0 | 4 |
_aDiabetes Complications _xphysiopathology |
| 650 | 0 | 4 |
_aDiabetic Neuropathies _xdrug therapy |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 |
_aHyperalgesia _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Neurologic Mutants |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xmetabolism |
| 650 | 0 | 4 |
_aNeural Conduction _xdrug effects |
| 650 | 0 | 4 |
_aPain Measurement _xmethods |
| 650 | 0 | 4 |
_aPain Threshold _xdrug effects |
| 650 | 0 | 4 |
_aPhosphodiesterase 5 Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
| 650 | 0 | 4 |
_aPurines _xtherapeutic use |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Leptin _xdeficiency |
| 650 | 0 | 4 |
_aSchwann Cells _xdrug effects |
| 650 | 0 | 4 |
_aSciatic Neuropathy _xdrug therapy |
| 650 | 0 | 4 | _aSildenafil Citrate |
| 650 | 0 | 4 |
_aSulfones _xtherapeutic use |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTransfection _xmethods |
| 700 | 1 | _aChopp, M | |
| 700 | 1 | _aSzalad, A | |
| 700 | 1 | _aLiu, Z | |
| 700 | 1 | _aBolz, M | |
| 700 | 1 | _aAlvarez, F M | |
| 700 | 1 | _aLu, M | |
| 700 | 1 | _aZhang, L | |
| 700 | 1 | _aCui, Y | |
| 700 | 1 | _aZhang, R L | |
| 700 | 1 | _aZhang, Z G | |
| 773 | 0 |
_tNeuroscience _gvol. 193 _gp. 399-410 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuroscience.2011.07.039 _zAvailable from publisher's website |
| 999 |
_c21065422 _d21065422 |
||